Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy

Extramedullary myeloma disease represents an infrequent but aggressive variant of multiple myeloma (MM), and it is associated with a poor prognosis. An optimal treatment strategy for this clinical subset has not yet been clarified. In this report, we demonstrate a patient with MM with the uncommon m...

Full description

Saved in:
Bibliographic Details
Main Authors: Fang-Yu Wang, Han-Kuang Hsieh, Tso-Fu Wang, Yi-Feng Wu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-04-01
Series:Journal of Cancer Research and Practice
Subjects:
Online Access:https://journals.lww.com/10.4103/ejcrp.eJCRP-D-22-00027
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591026839093248
author Fang-Yu Wang
Han-Kuang Hsieh
Tso-Fu Wang
Yi-Feng Wu
author_facet Fang-Yu Wang
Han-Kuang Hsieh
Tso-Fu Wang
Yi-Feng Wu
author_sort Fang-Yu Wang
collection DOAJ
description Extramedullary myeloma disease represents an infrequent but aggressive variant of multiple myeloma (MM), and it is associated with a poor prognosis. An optimal treatment strategy for this clinical subset has not yet been clarified. In this report, we demonstrate a patient with MM with the uncommon manifestation of plasmacytomas with a very high burden in the bilateral adrenal glands at diagnosis, which were treated successfully with daratumumab-based second-line therapy.
format Article
id doaj-art-541fcc4a12ca4406b46a6d3c05aee7a1
institution Kabale University
issn 2311-3006
language English
publishDate 2023-04-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Cancer Research and Practice
spelling doaj-art-541fcc4a12ca4406b46a6d3c05aee7a12025-01-23T05:05:12ZengWolters Kluwer Medknow PublicationsJournal of Cancer Research and Practice2311-30062023-04-01102788110.4103/ejcrp.eJCRP-D-22-00027Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based TherapyFang-Yu WangHan-Kuang HsiehTso-Fu WangYi-Feng WuExtramedullary myeloma disease represents an infrequent but aggressive variant of multiple myeloma (MM), and it is associated with a poor prognosis. An optimal treatment strategy for this clinical subset has not yet been clarified. In this report, we demonstrate a patient with MM with the uncommon manifestation of plasmacytomas with a very high burden in the bilateral adrenal glands at diagnosis, which were treated successfully with daratumumab-based second-line therapy.https://journals.lww.com/10.4103/ejcrp.eJCRP-D-22-00027adrenal plasmacytomadaratumumabextramedullary plasmacytomamultiple myeloma
spellingShingle Fang-Yu Wang
Han-Kuang Hsieh
Tso-Fu Wang
Yi-Feng Wu
Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy
Journal of Cancer Research and Practice
adrenal plasmacytoma
daratumumab
extramedullary plasmacytoma
multiple myeloma
title Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy
title_full Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy
title_fullStr Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy
title_full_unstemmed Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy
title_short Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy
title_sort bilateral bulky adrenal plasmacytomas with very good response to daratumumab based therapy
topic adrenal plasmacytoma
daratumumab
extramedullary plasmacytoma
multiple myeloma
url https://journals.lww.com/10.4103/ejcrp.eJCRP-D-22-00027
work_keys_str_mv AT fangyuwang bilateralbulkyadrenalplasmacytomaswithverygoodresponsetodaratumumabbasedtherapy
AT hankuanghsieh bilateralbulkyadrenalplasmacytomaswithverygoodresponsetodaratumumabbasedtherapy
AT tsofuwang bilateralbulkyadrenalplasmacytomaswithverygoodresponsetodaratumumabbasedtherapy
AT yifengwu bilateralbulkyadrenalplasmacytomaswithverygoodresponsetodaratumumabbasedtherapy